drugset / Trial / NCT02880865
Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine
Phase 4
Completed
628 enrolled
PATH
DFNet Research Inc. · collabResearch Institute for Tropical Medicine · collabSyneos Health · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This study aims to provide evidence that co-administration of measles-mumps-rubella vaccine (MMR) and live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) does not adversely affect immunogenicity or safety.
Timeline
- Start
- 2016-10-13
- Primary completion
- 2017-05-19
- Completion
- 2017-07-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD.JEVAX™ | Unknown | 0.5 ml | Subcutaneous |
| Subject | Measles-Mumps-Rubella Vaccine | Vaccine | 0.5 ml | Subcutaneous |